Calidi Biotherapeutics Files 8-K
Ticker: CLDWW · Form: 8-K · Filed: Sep 30, 2024 · CIK: 1855485
| Field | Detail |
|---|---|
| Company | Calidi Biotherapeutics, Inc. (CLDWW) |
| Form Type | 8-K |
| Filed Date | Sep 30, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, disclosure, financials
Related Tickers: CLDI
TL;DR
CLDI filed an 8-K on 9/30/24 for Reg FD and financials.
AI Summary
Calidi Biotherapeutics, Inc. filed an 8-K on September 30, 2024, reporting on a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as First Light Acquisition Group, Inc. until April 6, 2021, is incorporated in Delaware and based in San Diego, CA.
Why It Matters
This filing provides an update on the company's regulatory disclosures and financial reporting, which is important for investors to stay informed about the company's status.
Risk Assessment
Risk Level: low — This is a routine filing of an 8-K, which typically contains standard disclosures and financial information without immediate material impact.
Key Players & Entities
- Calidi Biotherapeutics, Inc. (company) — Registrant
- First Light Acquisition Group, Inc. (company) — Former Company Name
- April 6, 2021 (date) — Date of Name Change
- September 30, 2024 (date) — Date of Report
- San Diego, CA (location) — Company Business Address
FAQ
What is the primary purpose of this 8-K filing?
This 8-K filing serves as a Current Report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, reporting on Regulation FD Disclosure and Financial Statements and Exhibits.
When was Calidi Biotherapeutics, Inc. formerly known as?
Calidi Biotherapeutics, Inc. was formerly known as First Light Acquisition Group, Inc.
On what date did the company change its name?
The company's name change from First Light Acquisition Group, Inc. to Calidi Biotherapeutics, Inc. occurred on April 6, 2021.
Where is Calidi Biotherapeutics, Inc. headquartered?
Calidi Biotherapeutics, Inc. is located at 4475 Executive Drive, Suite 200, San Diego, CA 92121.
What is the company's state of incorporation?
Calidi Biotherapeutics, Inc. is incorporated in Delaware.
Filing Stats: 599 words · 2 min read · ~2 pages · Grade level 11.6 · Accepted 2024-09-30 09:10:10
Key Financial Figures
- $0.0001 — ch Registered Common stock, par value $0.0001 per share CLDI NYSE American LLC
Filing Documents
- form8-k.htm (8-K) — 41KB
- ex99-1.htm (EX-99.1) — 17KB
- ex99-1_001.jpg (GRAPHIC) — 15KB
- 0001493152-24-038718.txt ( ) — 305KB
- cldi-20240930.xsd (EX-101.SCH) — 4KB
- cldi-20240930_def.xml (EX-101.DEF) — 29KB
- cldi-20240930_lab.xml (EX-101.LAB) — 36KB
- cldi-20240930_pre.xml (EX-101.PRE) — 26KB
- form8-k_htm.xml (XML) — 6KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CALIDI BIOTHERAPEUTICS, INC. Dated: September 30, 2024 By: /s/ Andrew Jackson Name: Andrew Jackson Title: Chief Financial Officer